These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38922808)

  • 1. Alcohol-associated liver disease: Emerging therapeutic strategies.
    Mullish BH; Thursz MR
    Hepatology; 2024 Jun; ():. PubMed ID: 38922808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary Care of Alcohol-related Liver Disease and Alcohol Use Disorder: A Narrative Review for Hepatology and Addiction Clinicians.
    Shroff H; Gallagher H
    Clin Ther; 2023 Dec; 45(12):1177-1188. PubMed ID: 37813775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Pharmacotherapies in Alcohol-Associated Hepatitis.
    Wakil A; Niazi M; Meybodi MA; Pyrsopoulos NT
    J Clin Exp Hepatol; 2023; 13(1):116-126. PubMed ID: 36647403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical and allocation issues in liver transplant candidates with alcohol related liver disease.
    Sedki M; Ahmed A; Goel A
    Transl Gastroenterol Hepatol; 2022; 7():26. PubMed ID: 35892052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in alcoholic hepatitis.
    Veryan J; Forrest EH
    Frontline Gastroenterol; 2020 Mar; 11(2):133-139. PubMed ID: 32133112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol use disorder in alcohol-associated liver disease: Two sides of the same coin.
    Singal AK; Leggio L; DiMartini A
    Liver Transpl; 2024 Feb; 30(2):200-212. PubMed ID: 37934047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Management of Alcoholic Liver Disease.
    Dugum M; McCullough A
    J Clin Transl Hepatol; 2015 Jun; 3(2):109-16. PubMed ID: 26356792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.
    Singal AK; Kwo P; Kwong A; Liangpunsakul S; Louvet A; Mandrekar P; McClain C; Mellinger J; Szabo G; Terrault N; Thursz M; Winder GS; Kim WR; Shah VH
    Hepatology; 2022 Apr; 75(4):1026-1037. PubMed ID: 34496071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH).
    Arab JP; Roblero JP; Altamirano J; Bessone F; Chaves Araujo R; Higuera-De la Tijera F; Restrepo JC; Torre A; Urzua A; Simonetto DA; Abraldes JG; Méndez-Sánchez N; Contreras F; Lucey MR; Shah VH; Cortez-Pinto H; Bataller R
    Ann Hepatol; 2019; 18(3):518-535. PubMed ID: 31053546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol use disorder treatment and outcomes among hospitalized adults with alcoholic hepatitis.
    Winters AC; May FP; Wang Y; Shao P; Yang L; Patel AA
    Drug Alcohol Depend Rep; 2021 Dec; 1():100004. PubMed ID: 36843910
    [No Abstract]   [Full Text] [Related]  

  • 11. Gut Microbiome and Alcohol-associated Liver Disease.
    Philips CA; Schnabl B; Bajaj JS
    J Clin Exp Hepatol; 2022; 12(5):1349-1359. PubMed ID: 36157139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Medical Treatment for Alcohol-Associated Liver Disease.
    Ayares G; Idalsoaga F; Díaz LA; Arnold J; Arab JP
    J Clin Exp Hepatol; 2022; 12(5):1333-1348. PubMed ID: 36157148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Invasive Biomarkers for Differentiating Alcohol Associated Hepatitis from Acute Decompensation in Patients with ALD.
    Ignat M; Stefanescu H
    J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments.
    Argemi J; Ventura-Cots M; Rachakonda V; Bataller R
    Rev Esp Enferm Dig; 2020 Nov; 112(11):869-878. PubMed ID: 33054302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease.
    Fuenzalida C; Dufeu MS; Poniachik J; Roblero JP; Valenzuela-Pérez L; Beltrán CJ
    Front Pharmacol; 2021; 12():729950. PubMed ID: 34630107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): an attempted network meta-analysis.
    Buzzetti E; Kalafateli M; Thorburn D; Davidson BR; Thiele M; Gluud LL; Del Giovane C; Askgaard G; Krag A; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011646. PubMed ID: 28368093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcoholic liver disease: A current molecular and clinical perspective.
    Ohashi K; Pimienta M; Seki E
    Liver Res; 2018 Dec; 2(4):161-172. PubMed ID: 31214376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.